Ken Griffin Certara, Inc. Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Certara, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 5,000 shares of CERT stock, worth $56,050. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,000

Previous 8,000 37.5%

Holding current value

$56,050

Previous $110,000 47.27%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$10.46 - $16.58 $3.05 Million - $4.83 Million	291,243 Added 1173.23%	316,067 $3.7 Million
Q2 2024 Aug 14, 2024	SELL	$13.36 - $18.94 $374,667 - $531,153	-28,044 Reduced 53.05%	24,824 $343,000
Q1 2024 May 15, 2024	SELL	$15.65 - $19.45 $28,905 - $35,924	-1,847 Reduced 3.38%	52,868 $945,000
Q4 2023 Feb 14, 2024	SELL	$12.12 - $18.19 $332,778 - $499,442	-27,457 Reduced 33.41%	54,715 $962,000
Q3 2023 Nov 14, 2023	BUY	$13.9 - $19.58 $1.14 Million - $1.61 Million	82,172 New	82,172 $1.19 Million
Q4 2022 Feb 14, 2023	SELL	$10.7 - $17.84 $287,712 - $479,699	-26,889 Reduced 67.13%	13,164 $211,000
Q3 2022 Nov 14, 2022	BUY	$12.84 - $24.13 $514,280 - $966,478	40,053 New	40,053 $532,000
Q1 2022 May 16, 2022	SELL	$17.89 - $28.73 $2.15 Million - $3.45 Million	-120,147 Reduced 71.37%	48,190 $1.04 Million
Q4 2021 Feb 14, 2022	BUY	$26.1 - $45.21 $3.86 Million - $6.68 Million	147,768 Added 718.4%	168,337 $4.78 Million
Q3 2021 Nov 15, 2021	SELL	$24.46 - $38.41 $7.18 Million - $11.3 Million	-293,403 Reduced 93.45%	20,569 $681,000
Q4 2020 Feb 16, 2021	BUY	$33.59 - $40.18 $10.5 Million - $12.6 Million	313,972 New	313,972 $10.6 Million

Others Institutions Holding CERT

# of Institutions

232

Shares Held

105M

Call Options Held

26.4K

Put Options Held

19.2K

View Full List

About Certara, Inc.

Ticker CERT
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 159,899,008
Market Cap $1.79B
Description
Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company al...

More about CERT

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account